Bcr–Abl activates the AKT/FoxO3 signalling pathway to restrict transforming growth factor‐β‐mediated cytostatic signals

Authors:

Abstract
The fusion of Abl with either Bcr or Tel in human leukaemia leads to the constitutive activation of Abl tyrosine kinase, which in turn induces growth‐factor‐independent proliferation and cell survival. However, the mechanism by which Bcr–Abl induces cellular transformation has not yet been well characterized. Here, we show that Bcr–Abl‐expressing cells are resistant to growth inhibition and apoptosis mediated by transforming growth factor‐β (TGF‐β). Interestingly, we observed that the suppressive effects of Bcr–Abl on TGF‐β responses were not mediated by an impairment of Smad signalling, which is believed to act as the principal mediator of TGF‐β responses. In contrast, we found that Bcr–Abl can target the protein kinase AKT and the transcription factor FoxO3 to interfere with growth inhibition and apoptosis in response to TGF‐β. Our results show a novel mechanism of cellular transformation by the oncogenic fusion protein Bcr–Abl through suppression of the cytostatic actions of TGF‐β.

This publication has 22 references indexed in Scilit: